|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/00 | |
| G08B 1/08 | |||
| G08B 13/14 | |||
| G06K 5/00 | |||
| A61M 31/00 | |||
| A61B 5/07 | |||
| A61B 5/00 |
| (11) | Number of the document | 3235491 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17170017.2 |
| Date of filing the European patent application | 2009-03-05 | |
| (97) | Date of publication of the European application | 2017-10-25 |
| (45) | Date of publication and mention of the grant of the patent | 2020-11-04 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 34085 P | 2008-03-05 | US |
| (72) |
ROBERTSON, Timothy, US
ZDEBLICK, Mark J., US
|
| (73) |
Otsuka Pharmaceutical Co., Ltd.,
2-9, Kanda Tsukasa-machi Chiyoda-ku, Tokyo 101-8535,
JP
|
| (54) | MULTI-MODE COMMUNICATION INGESTIBLE EVENT MARKERS AND SYSTEMS |
| MULTI-MODE COMMUNICATION INGESTIBLE EVENT MARKERS AND SYSTEMS |